Samuel F. Hohmann, n/a

Research Analytics Director
Vizient, Center for Advanced Analytic

Disclosure(s): No financial relationships to disclose

Poster(s):

• 652 - Ceftazidime-avibactam Alone or as Combination Therapy? Multicenter Retrospective Cohort Analysis of Clinical Outcomes in Patients with Carbapenem-resistant Gram-negative Infection
  Thursday, October 20, 2022

  12:15 PM – 1:30 PM US ET